Select for export A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.drugalcdep.2012.11.010 PubMed 23265089 Copy citation Copy BibTeX Unknown journal 2012-12-20 Hallock RM, Dean A, Knecht ZA, Spencer J, Taverna EC. Europe PMC Published psilocybin AddictionMystical ExperienceObservational Study Observational Study More
Select for export Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00414-012-0796-1 PubMed 23183899 Copy citation Copy BibTeX Unknown journal 2012-11-26 Martin R, Schürenkamp J, Gasse A, Pfeiffer H, Köhler H. Europe PMC Published psilocybinpsilocin Toxicity Clinical Trial More
Select for export Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2012.736842 PubMed 23457892 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2012-10-31 Lyvers M, Meester M. Europe PMC Published psilocybin DepressionAnxietyAddiction Observational Study More
Select for export Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/schbul/sbs117 PubMed 23044373 Copy citation Copy BibTeX Schizophrenia Bulletin 2012-10-07 Carhart-Harris RL, Leech R, Erritzoe D, Williams TM, Stone JM, Evans J Europe PMC Published psilocybin Brain ImagingDefault Mode NetworkAging Other More
Select for export Animal models of serotonergic psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/cn300138m PubMed 23336043 Copy citation Copy BibTeX Unknown journal 2012-09-23 Hanks JB, González-Maeso J. Europe PMC Published psilocybin AnxietyMechanism of ActionReceptor Pharmacology Review Article More
Select for export Moral transhumanism: the next step. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/jmp/jhs024 PubMed 22855738 Copy citation Copy BibTeX The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine 2012-07-31 Tennison MN. Europe PMC Published psilocybin Safety Other More
Select for export The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-012-2811-0 PubMed 22836372 Copy citation Copy BibTeX Psychopharmacology 2012-07-26 Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F. Europe PMC Published psilocybin Receptor PharmacologyEmotional Processing Other More
Select for export Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/hup.2234 PubMed 22696164 Copy citation Copy BibTeX Human Psychopharmacology Clinical and Experimental 2012-06-13 Licht CL, Christoffersen M, Okholm M, Damgaard L, Fink-Jensen A, Knudsen GM Europe PMC Published psilocybin AddictionObservational StudyAdolescents Observational Study More
Select for export Substance use initiation: the role of simultaneous polysubstance use. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/j.1465-3362.2012.00470.x PubMed 22612987 Copy citation Copy BibTeX Drug and Alcohol Review 2012-05-20 Olthuis JV, Darredeau C, Barrett SP. Europe PMC Published psilocybin AddictionAdolescentsSafety Other More
Select for export Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2012.04.005 PubMed 22578254 Copy citation Copy BibTeX Biological Psychiatry 2012-05-09 Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-012-2680-6 PubMed 22526529 Copy citation Copy BibTeX Unknown journal 2012-04-12 Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. Europe PMC Published psilocybin AnxietyHeadache / MigraineSpirituality Observational Study More
Select for export Neuroimaging: a scanner, colourfully. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.cub.2012.02.033 PubMed 22497939 Copy citation Copy BibTeX Unknown journal 2012-03-31 Roiser JP, Rees G. Europe PMC Published psilocybin DepressionBrain ImagingAging Other More
Select for export Prediction of psilocybin response in healthy volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0030800 PubMed 22363492 Copy citation Copy BibTeX PLoS ONE 2012-02-16 Studerus E, Gamma A, Kometer M, Vollenweider FX. Europe PMC Published psilocybin AnxietyPersonality ChangeEmotional Processing Other More
Select for export Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjp.bp.111.103309 PubMed 22282432 Copy citation Copy BibTeX The British Journal of Psychiatry 2012-01-25 Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T Europe PMC Published psilocybin Brain ImagingAgingEmotional Processing Clinical Trial More
Select for export Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1073/pnas.1119598109 PubMed 22308440 Copy citation Copy BibTeX Proceedings of the National Academy of Sciences 2012-01-22 Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A Europe PMC Published psilocybin Brain ImagingConsciousnessAging Other More
Select for export A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00414-011-0652-8 PubMed 22138681 Copy citation Copy BibTeX Unknown journal 2011-12-02 Martin R, Schürenkamp J, Pfeiffer H, Köhler H. Europe PMC Published psilocybinpsilocin General Clinical Trial More
Select for export Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.drugalcdep.2011.10.029 PubMed 22129843 Copy citation Copy BibTeX Drug and Alcohol Dependence 2011-11-28 Johnson MW, Sewell RA, Griffiths RR. Europe PMC Published psilocybin Headache / MigraineMechanism of ActionHealthy Volunteers Other More
Select for export Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/npp.2011.261 PubMed 22030715 Copy citation Copy BibTeX Unknown journal 2011-10-25 Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyConsciousness Other More
Select for export Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881111420188 PubMed 21956378 Copy citation Copy BibTeX Journal of Psychopharmacology 2011-09-27 MacLean KA, Johnson MW, Griffiths RR. Europe PMC Published psilocybin Personality ChangeCreativitySpirituality Randomized Controlled Trial More
Select for export Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/npp.2011.228 PubMed 21956447 Copy citation Copy BibTeX Neuropsychopharmacology 2011-09-27 Quednow BB, Kometer M, Geyer MA, Vollenweider FX. Europe PMC Published psilocybinpsilocin Receptor PharmacologyConsciousnessObservational Study Clinical Trial More
